228 related articles for article (PubMed ID: 30650583)
21. Substrate selectivity of monoamine oxidase A, monoamine oxidase B, diamine oxidase, and semicarbazide-sensitive amine oxidase in COS-1 expression systems.
Ochiai Y; Itoh K; Sakurai E; Adachi M; Tanaka Y
Biol Pharm Bull; 2006 Dec; 29(12):2362-6. PubMed ID: 17142964
[TBL] [Abstract][Full Text] [Related]
22. Glucose handling in streptozotocin-induced diabetic rats is improved by tyramine but not by the amine oxidase inhibitor semicarbazide.
Visentin V; Bour S; Boucher J; Prévot D; Valet P; Ordener C; Parini A; Carpéné C
Eur J Pharmacol; 2005 Oct; 522(1-3):139-46. PubMed ID: 16202994
[TBL] [Abstract][Full Text] [Related]
23. Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 deficiency reduces leukocyte infiltration into adipose tissue and favors fat deposition.
Bour S; Caspar-Bauguil S; Iffiú-Soltész Z; Nibbelink M; Cousin B; Miiluniemi M; Salmi M; Stolen C; Jalkanen S; Casteilla L; Pénicaud L; Valet P; Carpéné C
Am J Pathol; 2009 Mar; 174(3):1075-83. PubMed ID: 19218346
[TBL] [Abstract][Full Text] [Related]
24. Molecular cloning of a major mRNA species in murine 3T3 adipocyte lineage. differentiation-dependent expression, regulation, and identification as semicarbazide-sensitive amine oxidase.
Moldes M; Fève B; Pairault J
J Biol Chem; 1999 Apr; 274(14):9515-23. PubMed ID: 10092636
[TBL] [Abstract][Full Text] [Related]
25. Anti-inflammatory effects of inhibiting the amine oxidase activity of semicarbazide-sensitive amine oxidase.
Salter-Cid LM; Wang E; O'Rourke AM; Miller A; Gao H; Huang L; Garcia A; Linnik MD
J Pharmacol Exp Ther; 2005 Nov; 315(2):553-62. PubMed ID: 16081681
[TBL] [Abstract][Full Text] [Related]
26. The lysyl oxidase inhibitor β-aminopropionitrile reduces body weight gain and improves the metabolic profile in diet-induced obesity in rats.
Miana M; Galán M; Martínez-Martínez E; Varona S; Jurado-López R; Bausa-Miranda B; Antequera A; Luaces M; Martínez-González J; Rodríguez C; Cachofeiro V
Dis Model Mech; 2015 Jun; 8(6):543-51. PubMed ID: 26035864
[TBL] [Abstract][Full Text] [Related]
27. Semicarbazide-sensitive amine oxidase activation promotes adipose conversion of 3T3-L1 cells.
Mercier N; Moldes M; El Hadri K; Fève B
Biochem J; 2001 Sep; 358(Pt 2):335-42. PubMed ID: 11513731
[TBL] [Abstract][Full Text] [Related]
28. Increased primary amine oxidase expression and activity in white adipose tissue of obese and diabetic db-/- mice.
Iffiú-Soltész Z; Mercader J; Daviaud D; Boucher J; Carpéné C
J Neural Transm (Vienna); 2011 Jul; 118(7):1071-7. PubMed ID: 21298297
[TBL] [Abstract][Full Text] [Related]
29. Absence of tissue-bound semicarbazide-sensitive amine oxidase activity in carp tissues.
Takahashi K; Kakuta I; Sugimoto H; Obata T; Oreland L; Kinemuchi H
Life Sci; 2007 Feb; 80(12):1094-9. PubMed ID: 17215008
[TBL] [Abstract][Full Text] [Related]
30. Adipocytes release a soluble form of VAP-1/SSAO by a metalloprotease-dependent process and in a regulated manner.
Abella A; García-Vicente S; Viguerie N; Ros-Baró A; Camps M; Palacín M; Zorzano A; Marti L
Diabetologia; 2004 Mar; 47(3):429-438. PubMed ID: 14968297
[TBL] [Abstract][Full Text] [Related]
31. The effects of chronic administration of inhibitors of flavin and quinone amine oxidases on imidazoline I(1) receptor density in rat whole brain.
Holt A; Todd KG; Baker GB
Ann N Y Acad Sci; 2003 Dec; 1009():309-22. PubMed ID: 15028605
[TBL] [Abstract][Full Text] [Related]
32. Studies of monoamine oxidase and semicarbazide-sensitive amine oxidase. I. Inhibition by a selective monoamine oxidase-B inhibitor, MD 780236.
Kinemuchi H; Morikawa F; Ueda T; Arai Y
Jpn J Pharmacol; 1986 Jun; 41(2):183-9. PubMed ID: 3747265
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, and biological evaluation of semicarbazide-sensitive amine oxidase (SSAO) inhibitors with anti-inflammatory activity.
Wang EY; Gao H; Salter-Cid L; Zhang J; Huang L; Podar EM; Miller A; Zhao J; O'rourke A; Linnik MD
J Med Chem; 2006 Apr; 49(7):2166-73. PubMed ID: 16570912
[TBL] [Abstract][Full Text] [Related]
34. Amine oxidase substrates for impaired glucose tolerance correction.
Carpéné C; Bour S; Visentin V; Pellati F; Benvenuti S; Iglesias-Osma MC; García-Barrado MJ; Valet P
J Physiol Biochem; 2005 Jun; 61(2):405-19. PubMed ID: 16180339
[TBL] [Abstract][Full Text] [Related]
35. Oral Phenelzine Treatment Mitigates Metabolic Disturbances in Mice Fed a High-Fat Diet.
Mercader J; Sabater AG; Le Gonidec S; Decaunes P; Chaplin A; Gómez-Zorita S; Milagro FI; Carpéné C
J Pharmacol Exp Ther; 2019 Nov; 371(2):555-566. PubMed ID: 31270215
[TBL] [Abstract][Full Text] [Related]
36. Synthetic polyamines as potential amine oxidase inhibitors: a preliminary study.
Emanuela B; Minarini A; Tumiatti V; Milelli A; Lunelli M; Pegoraro M; Rizzoli V; Di Paolo ML
Amino Acids; 2012 Feb; 42(2-3):913-28. PubMed ID: 21858471
[TBL] [Abstract][Full Text] [Related]
37. Piceatannol and resveratrol share inhibitory effects on hydrogen peroxide release, monoamine oxidase and lipogenic activities in adipose tissue, but differ in their antilipolytic properties.
Les F; Deleruyelle S; Cassagnes LE; Boutin JA; Balogh B; Arbones-Mainar JM; Biron S; Marceau P; Richard D; Nepveu F; Mauriège P; Carpéné C
Chem Biol Interact; 2016 Oct; 258():115-25. PubMed ID: 27475863
[TBL] [Abstract][Full Text] [Related]
38. Anti-inflammatory effects of LJP 1586 [Z-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride], an amine-based inhibitor of semicarbazide-sensitive amine oxidase activity.
O'Rourke AM; Wang EY; Miller A; Podar EM; Scheyhing K; Huang L; Kessler C; Gao H; Ton-Nu HT; Macdonald MT; Jones DS; Linnik MD
J Pharmacol Exp Ther; 2008 Feb; 324(2):867-75. PubMed ID: 17993604
[TBL] [Abstract][Full Text] [Related]
39. Stereochemistry and cofactor identity status of semicarbazide-sensitive amine oxidases.
Palcic MM; Scaman CH; Alton G
Prog Brain Res; 1995; 106():41-7. PubMed ID: 8584672
[TBL] [Abstract][Full Text] [Related]
40. Selective inhibitors of membrane-bound semicarbazide-sensitive amine oxidase (SSAO) activity in mammalian tissues.
Kinemuchi H; Sugimoto H; Obata T; Satoh N; Ueda S
Neurotoxicology; 2004 Jan; 25(1-2):325-35. PubMed ID: 14697907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
